Recursion Pharmaceuticals Inc vs Tidewater Inc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B), while Tidewater Inc trades at $91 (market cap $4.54B). The key difference: Tidewater Inc is far larger — about 2.5× Recursion Pharmaceuticals Inc's market cap, and Tidewater Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RXRX | TDW | |
|---|---|---|
Market Cap | $1.81B | $4.54B |
Sector | Health | Utilities |
52-Week High | $6.79 | $91.20 |
52-Week Low | $2.84 | $47.29 |
Enterprise Value | $1.33B | $4.58B |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →